According to the Latest reports by DataM Intelligence the Premenstrual Syndrome (PMS) Treatment Market presents a significant growth opportunity, with a projected value of USD 1.829 billion by 2031, representing a CAGR of 4.1% from 2024.
DataM Intelligence Profiles Top 10 Key Premenstrual Syndrome Treatment Market
1) Eli Lilly and Company:
Eli Lilly and Company, a leading innovation-driven corporation, has been at the forefront of pharmaceutical development, boasting a robust portfolio of first-in-class and best-in-class products. Harnessing cutting-edge research from its global laboratories and collaborations with leading scientific organizations, Lilly focuses on treatments for conditions like bone, muscle, and joint disorders, cancer, cardiovascular diseases, diabetes, endocrine disorders, immunology, neurodegeneration, neuroscience, and pain. Committed to delivering innovative medicines, Lilly also promotes its products through sales representatives and strategic marketing agreements with other pharmaceutical companies.
Financial Performance:
|
Year |
Revenue (US$ Mn) |
|
2020 |
24,539.80 |
|
2021 |
28,318.40 |
|
2022 |
28,541.40 |
2) Sebela Pharmaceuticals
Sebela Pharmaceuticals, a U.S.-based company, holds a market-leading position in Gastroenterology and emphasizes innovation in Women's Health. Their strategy aims to enhance patient lives through groundbreaking pharmaceuticals, particularly in developing advanced colonoscopy preparations and exploring new Gastroenterology indications. Sebela's growth strategy involves building a pipeline of unique products critical to patients' needs.
Key Products:
- PEXEVA: An SSRI for treating Major Depressive Disorder, Obsessive Compulsive Disorder, Panic Disorder, and Generalized Anxiety Disorder.
- BRISDELLE: An SSRI for managing moderate to severe vasomotor symptoms associated with menopause.
3) Pfizer Inc.
Pfizer Inc., an American multinational pharmaceutical giant, is renowned for developing and producing a wide array of medicines and vaccines across various medical fields including immunology, oncology, cardiology, endocrinology, and neurology. The company’s extensive portfolio of over 150 products spans 15 therapeutic areas, providing significant value to healthcare providers and patients by treating diseases and enhancing health and wellness. In March 2023, Pfizer introduced its new Purpose Blueprint, outlining 15 Big Ideas and 5 New Principles to guide the company towards its ambitious goal of "Changing a billion lives a year" by 2027.
Key Products:
- ZOLOFT (Sertraline Hydrochloride) Tablets: An SSRI indicated for Major Depressive Disorder, Obsessive-Compulsive Disorder, Panic Disorder, Post-Traumatic Stress Disorder, Social Anxiety Disorder, and Premenstrual Dysphoric Disorder.
- Norminest Fe Tablets: Used for the prevention of pregnancy in women opting for contraceptive methods.
- TRIPHASIL-21: A combination hormone medication containing progestin and estrogen, used to prevent pregnancy.
|
Parameters
|
2020
|
2021 |
2022
|
|
Net sales
|
41,651
|
81,288
|
100,330 |
|
Operating income
|
6,666
|
22,459
|
31,401
|
|
Net income |
9,159
|
21,979
|
31,372 |
4) GSK
GSK, a major healthcare player, operates through two segments: pharmaceuticals and vaccines. Their research efforts target six key areas: respiratory diseases, HIV/AIDS and other infectious diseases, vaccines, immuno-inflammation, oncology, and rare diseases.
Through its pharmaceutical business, GSK discovers, develops, and commercializes medicines for various acute and chronic illnesses. They also offer a comprehensive range of vaccines for children and adults, aiming to contribute to global immunization efforts. They are committed to launching new vaccines by 2026, leveraging their strong manufacturing capabilities and global reach.
Some of GSK's prescription medications include PAXIL (paroxetine hydrochloride) for treating major depressive disorder, anxiety disorders, and PTSD in adults. PAXIL CR is another prescription medication used for depression, panic disorder, and premenstrual dysphoric disorder.
Financial Performance:
|
Year |
Revenue (US$ Mn) |
|
2020 |
46,543.62 |
|
2021 |
45,981.72 |
|
2022 |
35,235.45 |
5) HALEON PLC.
Haleon Plc. isn't your average healthcare company. This global leader in consumer health, with a 7.3% market share in over-the-counter medicines, prioritizes inclusivity and empowerment.
Haleon goes beyond simply offering well-known brands like Sensodyne toothpaste, Panadol, Advil painkillers, and Centrum vitamins. They champion inclusivity through impactful campaigns and educational programs, aiming to empower people to take charge of their health.
Haleon caters to various health needs with a strong brand portfolio across five categories: Oral Health, Vitamins, Minerals & Supplements, Pain Relief, Respiratory Support, Digestive Health, and more.
6) Johnson & Johnson.
Johnson & Johnson (J&J) is a titan in the healthcare industry, encompassing research, development, manufacturing, and sales. This holding company operates through three major segments:
· Consumer Health: This segment focuses on everyday healthcare needs, providing trusted products in baby care, oral care, beauty, over-the-counter pharmaceuticals, women's health, and wound care. Examples include familiar brands like Band-Aid, Neutrogena, and Tylenol.
· Pharmaceutical: J&J's pharmaceutical arm tackles complex medical challenges. They focus on research and development in areas like immunology, infectious diseases, neuroscience, and more.
· MedTech: This segment offers advanced medical devices and technologies used by healthcare professionals across various specialties.
J&J actively collaborates with academic institutions, research organizations, and other pharmaceutical companies. This collaborative approach fosters scientific progress and the development of novel treatment options.
7) Bayer AG
A global titan in pharmaceuticals and life sciences, Bayer reaches far beyond its household name - Aspirin. They address a wide range of healthcare needs through human and veterinary prescription medications, with a focus on cardiology, women's health, and specialty areas like oncology.
Bayer also offers over-the-counter solutions like Aspirin for pain relief, catering to consumer health needs.
Additionally, their reach extends beyond pharmaceuticals with their involvement in agricultural solutions, including chemicals, seeds, and biotechnology products. This diverse portfolio, coupled with its global presence across continents like Europe, North America, and Asia Pacific, positions Bayer as a key player in advancing healthcare and life sciences on a worldwide scale.
8) Novo Nordisk A/S
Novo Nordisk A/S stands out as a Danish multinational powerhouse in pharmaceuticals. They are a full member of the European Federation of Pharmaceutical Industries and Associations, demonstrating their commitment to industry standards. While diabetes treatment remains their core focus, offering medications like NovoLog, Levemir, and Tresiba, Novo Nordisk's reach extends beyond.
They are also active in hormone replacement therapy, growth hormone therapy, and hemostasis control, showcasing a diverse range of healthcare solutions. Their global presence is impressive, with products reaching patients in approximately 170 countries. This commitment to innovation and worldwide availability positions Novo Nordisk as a key player in advancing healthcare on a global scale.
9) Lupin Limited (Parent Company)
Lupin Limited carved a niche as a global pharmaceutical player, extending beyond just branded medications. They excel in both branded and generic formulations, biosimilars, and active pharmaceutical ingredients (APIs). Their focus areas are diverse, encompassing cardiovascular, diabetes, asthma, pediatrics, and more.
Lupin is a leader in the anti-tuberculosis segment and actively conducts research and development across various therapeutic areas like migraine, gastrointestinal issues, and central nervous system disorders. Furthermore, they strategically build targeted pipelines in specific regions, focusing on women's health in the USA, neurology in Europe and Japan, and areas like cardiology, diabetes, and respiratory in India and Latin America. This comprehensive approach positions Lupin as a key player in advancing healthcare solutions globally.
10) AbbVie.
AbbVie Inc., a biopharmaceutical powerhouse spun off from Abbott Laboratories in 2011, dedicates itself to discovering, developing, and delivering treatments for chronic and complex diseases.
They focus on research-based pharmaceuticals and market their products directly to various healthcare providers, including wholesalers, hospitals, and specialty pharmacies. AbbVie prioritizes areas like hormonal disorders, including thyroid issues, and women's health concerns like heavy menstrual bleeding.
This focus on innovation and accessibility positions them as a key player in tackling challenging health conditions.
